Development of an isogenic human cell trio that models polyglutamine disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of an isogenic human cell trio that models polyglutamine disease
Authors
Keywords
-
Journal
GENES & GENETIC SYSTEMS
Volume 98, Issue 4, Pages 179-189
Publisher
Genetics Society of Japan
Online
2023-10-11
DOI
10.1266/ggs.22-00030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biallelic and gene-wide genomic substitution for endogenous intron and retroelement mutagenesis in human cells
- (2022) Tomoyuki Ohno et al. Nature Communications
- Use of single guided Cas9 nickase to facilitate precise and efficient genome editing in human iPSCs
- (2021) Pan P. Li et al. Scientific Reports
- CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells
- (2021) Lang He et al. Translational Psychiatry
- Generation of New Isogenic Models of Huntington’s Disease Using CRISPR-Cas9 Technology
- (2020) Magdalena Dabrowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis – Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial)
- (2019) Satoru Morimoto et al. Regenerative Therapy
- Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
- (2018) Ronen Ben Jehuda et al. Stem Cell Reviews and Reports
- Genome Editing in Induced Pluripotent Stem Cells using CRISPR/Cas9
- (2018) Ronen Ben Jehuda et al. Stem Cell Reviews and Reports
- Polyglutamine Repeats in Neurodegenerative Diseases
- (2018) Andrew P. Lieberman et al. Annual Review of Pathology-Mechanisms of Disease
- Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent
- (2018) Koki Fujimori et al. NATURE MEDICINE
- Reversal of Phenotypic Abnormalities by CRISPR/Cas9-Mediated Gene Correction in Huntington Disease Patient-Derived Induced Pluripotent Stem Cells
- (2017) Xiaohong Xu et al. Stem Cell Reports
- Pluripotent stem cells in disease modelling and drug discovery
- (2016) Yishai Avior et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271
- (2016) Adele G. Marthaler et al. Stem Cell Research
- Ataxin-2 Regulates RGS8 Translation in a New BAC-SCA2 Transgenic Mouse Model
- (2015) Warunee Dansithong et al. PLoS Genetics
- CRISPRdirect: software for designing CRISPR/Cas guide RNA with reduced off-target sites
- (2014) Yuki Naito et al. BIOINFORMATICS
- Investigating human disease using stem cell models
- (2014) Jared L. Sterneckert et al. NATURE REVIEWS GENETICS
- Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
- (2014) Foad Rouhani et al. PLoS Genetics
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- The Chicken Hypersensitivity Site 4 Core Insulator Blocks Promoter Interference in Lentiviral Vectors
- (2013) Naoya Uchida et al. Human Gene Therapy Methods
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations
- (2011) Frank Soldner et al. CELL
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
- (2010) Andrew C. Elden et al. NATURE
- Elite and stochastic models for induced pluripotent stem cell generation
- (2009) Shinya Yamanaka NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now